首页> 外文期刊>Breast cancer >Fat necrosis after breast-conserving oncoplastic surgery
【24h】

Fat necrosis after breast-conserving oncoplastic surgery

机译:保留乳房整形手术后的脂肪坏死

获取原文
           

摘要

Background Fat necrosis is a subjective early as well as delayed complication, which sometimes mimics local recurrence and ruins the quality of life by pain and poor cosmetic result. While, the frequency and severity of fat necrosis are important issues that breast surgeons should explain to the patient, these data are not revealed well. Methods A total of 1476 patients who underwent breast surgery from January 2000 to December 2012 were enrolled in the present study. We assessed fat necrosis by mammographic and physical findings and created grading criteria: Grade (G) 0, no fat necrosis; G1, no symptomatic fat necrosis (mammographic dystrophic calcification); G2, mild symptomatic necrosis (mammographic dystrophic necrosis with tumor); G3, severe symptomatic necrosis (mammographic dystrophic necrosis with pain or skin change); and G4, symptomatic necrosis requiring surgical intervention. Results Of the 1476 patients enrolled, 393 (27%) underwent mastectomy, and 1083 (73%) underwent breast-conserving surgery. We achieved a high rate of breast-conserving surgery at a total rate of 73% over the study period and maximum rate of 88% in 2010, using oncoplastic procedures. We mainly adopted a pedicled fat flap (417/1083; 39%) and a free dermal fat flap (40/1083; 3.7%). Among the 626 patients who underwent partial resection with no replacement for the defect, G1–G2 fat necrosis was seen in 29/626 (4.6%). While, the incidence of fat necrosis with pedicled fat flap and free dermal fat graft was 68/417 (16%) and 40/40 (100%), respectively, showing a significant difference ( p ?
机译:背景脂肪坏死是一种主观的早期及延迟并发症,有时模仿局部复发,并因疼痛和美容效果差而破坏生活质量。尽管脂肪坏死的发生频率和严重程度是乳房外科医师应向患者解释的重要问题,但这些数据并未得到很好的揭示。方法从2000年1月至2012年12月,共纳入1476例行乳房手术的患者。我们通过乳腺X线摄影和物理检查结果评估了脂肪坏死,并制定了评分标准:等级(G)0,无脂肪坏死; G1,无症状性脂肪坏死(乳房X光检查营养不良钙化); G2,轻度症状性坏死(乳房X线摄影性营养不良性坏死伴肿瘤); G3,严重症状性坏死(乳房X线摄影性营养不良性坏死伴有疼痛或皮肤改变);和G4,有症状的坏死需要手术干预。结果纳入的1476例患者中,有393例(27%)接受了乳房切除术,而1083例(73%)进行了保乳手术。在研究期间,我们采用了整形外科手术,保乳手术率很高,总研究率达到73%,2010年最高达到88%。我们主要采用带蒂脂肪皮瓣(417/1083; 39%)和游离真皮脂肪皮瓣(40/1083; 3.7%)。在626例接受部分切除且无缺损的患者中,G1–G2脂肪坏死发生在29/626位(4.6%)。同时,带蒂脂肪瓣和游离真皮脂肪移植物的脂肪坏死发生率分别为68/417(16%)和40/40(100%),显示出显着性差异(p≤0.01)。此外,游离真皮脂肪移植物的G3-G4脂肪坏死的发生率(25%; 10/40)显着高于椎弓根皮瓣(2.9%; 12/417)(p <0.01)。在带蒂皮瓣中,乳腺下脂肪筋膜皮瓣脂肪坏死的发生率为56%(14/25),高于侧皮表皮脂肪皮瓣的脂肪坏死的发生率(12%; 33/276)(p <0.01),乳腺周围组织(8%; 21/116)(p <0.01)。乳房下脂肪筋膜皮瓣中G3脂肪坏死的发生率也很高,为20%(5/25)。结论保留乳房的肿瘤整形手术具有延迟发生脂肪坏死的风险。应评估每种手术中脂肪坏死的发生率和严重程度。我们应该选择血液供应充足的脂肪移植物,以替代保乳疗法的缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号